Form C-AR — Aspire BioPharma Inc.
0001493152-24-016259 · filed Apr 26, 2024
Offering
- Target
- —
- Maximum
- —
- Security type
- —
- Price per security
- —
- Deadline
- —
- Oversubscription
- —
Issuer
- CIK
- 1995528
- Entity
- Corporation
- Jurisdiction
- PR
- Address
- 194 Candelaro Drive
Humacao, PR 00791 - Phone
- —
Most recent fiscal year financials
- Total assets
- $5,017,181
- Cash
- —
- Short-term debt
- $652,490
- Long-term debt
- $3,852,552
- Revenues
- —
- COGS
- —
- Taxes paid
- —
- Net income
- $-359,071
View the original filing on SEC EDGAR ↗